Does RIFAXIMIN Cause Hepatic encephalopathy? 462 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 462 reports of Hepatic encephalopathy have been filed in association with RIFAXIMIN (XIFAXAN). This represents 3.3% of all adverse event reports for RIFAXIMIN.
462
Reports of Hepatic encephalopathy with RIFAXIMIN
3.3%
of all RIFAXIMIN reports
93
Deaths
347
Hospitalizations
How Dangerous Is Hepatic encephalopathy From RIFAXIMIN?
Of the 462 reports, 93 (20.1%) resulted in death, 347 (75.1%) required hospitalization, and 8 (1.7%) were considered life-threatening.
Is Hepatic encephalopathy Listed in the Official Label?
Yes, Hepatic encephalopathy is listed as a known adverse reaction in the official FDA drug label for RIFAXIMIN.
What Other Side Effects Does RIFAXIMIN Cause?
Death (3,687)
Hospitalisation (1,605)
Therapy interrupted (875)
Off label use (802)
Diarrhoea (709)
Ammonia increased (676)
Inability to afford medication (672)
Insurance issue (577)
Confusional state (530)
Hepatic cirrhosis (480)
What Other Drugs Cause Hepatic encephalopathy?
ACETAMINOPHEN (562)
RIBAVIRIN (512)
LENVATINIB (502)
SOFOSBUVIR (360)
BEVACIZUMAB (210)
LEDIPASVIR\SOFOSBUVIR (180)
ATEZOLIZUMAB (178)
SORAFENIB (169)
DACLATASVIR (165)
FUROSEMIDE (130)
Which RIFAXIMIN Alternatives Have Lower Hepatic encephalopathy Risk?
RIFAXIMIN vs RILMENIDINE
RIFAXIMIN vs RILONACEPT
RIFAXIMIN vs RILPIVIRINE
RIFAXIMIN vs RILUZOLE
RIFAXIMIN vs RIMABOTULINUMTOXINB